PERSON – Page 11

Trump tariffs, drug shortages, price increases, pharmaceutical industry, trade groups, supply chain disruption, generic drugs, active pharmaceutical ingredients (APIs)

Senator Cassidy’s Crucial Vote Advances RFK Jr.’s HHS Secretary Nomination

3 months ago talkbio0Tagged Administration occupational activities, Bill Cassidy, CHARGE Syndrome, HHS, public health medicine (field), Robert F. Kennedy, Secretary Nomination, Senate Finance Committee, Transplant Registry Unified Management Program, Vaccines

Robert F. Kennedy Jr., Bill Cassidy, HHS Secretary nomination, Senate Finance Committee, vaccine safety, public health, Trump administration

Trump’s Tariffs Threaten to Disrupt Healthcare Supply Chain and Increase Costs

3 months ago talkbio0Tagged Drug Industry, Drug shortages, Health care facility, Import, Medical Devices, medical supply chain, Trump tariffs

Trump tariffs, medical supply chain, healthcare costs, drug shortages, medical devices, pharmaceutical industry, import taxes

Trump Imposes New Tariffs on Canada, Mexico, and China; Medical Industry Seeks Exemptions

3 months ago talkbio0Tagged Canada, China, fentanyl crisis, illegal immigration, medical technology exemptions, Mexico, National Security, Policy, TNFRSF19 gene, Trump tariffs

Trump tariffs, Canada, Mexico, China, medical technology exemptions, trade policy, national security, fentanyl crisis, illegal immigration

NHS England Approves Groundbreaking CRISPR Gene Therapy for Sickle Cell Disease

3 months ago talkbio0Tagged Anemia, Sickle Cell, Approved, Casgevy, Clustered Regularly Interspaced Short Palindromic Repeats, England, exagamglogene autotemcel, gene therapy, Nance-Horan syndrome, NICE, Nitroglycerin/Sodium Citrate/Ethanol Solution

Casgevy, exagamglogene autotemcel, CRISPR gene therapy, sickle cell disease, NHS England, Vertex Pharmaceuticals, NICE approval

FDA Approves Axsome’s Symbravo for Rapid Migraine Relief

3 months ago talkbio0Tagged acute, Approved, Axsome Therapeutics', meloxicam, Migraine Disorders, rizatriptan, Symbravo, United States Food and Drug Administration

Symbravo, meloxicam, rizatriptan, FDA approval, acute migraine treatment, rapid-acting, Axsome Therapeutics

FDA Approves Axsome’s Symbravo for Acute Migraine Treatment, Overcoming 2022 Rejection

3 months ago talkbio0Tagged acute, Approved, meloxicam, Migraine Disorders, MoSEIC, rizatriptan, Symbravo, Technology, United States Food and Drug Administration

Symbravo, Axsome Therapeutics, FDA approval, acute migraine treatment, meloxicam, rizatriptan, MoSEIC technology